Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Loxo Oncology, Inc.

Clinical trials sponsored by Loxo Oncology, Inc., explained in plain language.

Now part of Eli Lilly and Company LLY NYSE

Cancer-focused biotech acquired by Eli Lilly.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 5 Completed 1

New pill shows promise for Hard-to-Treat blood cancers

Disease control Completed

This study tested an oral drug called LOXO-305 (pirtobrutinib) in 803 people with chronic lymphocytic leukemia, small lymphocytic lymphoma, or other non-Hodgkin lymphomas whose cancer had stopped responding to or could not tolerate standard treatments. The goal was to find the be…

Phase: PHASE1, PHASE2 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC